Back
Janux Therapeutics 10K Form
Sell
34
JANX
Janux Therapeutics
Last Price:
41.31
Seasonality Move:
-14.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive JANX News And Ratings
See the #1 stock for the next 7 days that we like better than JANX
JANX Financial Statistics
Sales & Book Value
Annual Sales: | $8.08M |
---|---|
Cash Flow: | $-10.12M |
Price / Cash Flow: | 0 |
Annual Sales: | $12.61 |
Price / Book: | 3.27 |
Profitability
EPS (TTM): | -0.90000 |
---|---|
Net Income (TTM): | $-44.05M |
Gross Margin: | -- |
Return on Equity: | -9.55% |
Return on Assets: | -8.85% |
Janux Therapeutics Earnings Forecast
Key Janux Therapeutics Financial Ratios
- The Research & Development expenses have been 679.48% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of JANX is -721.18% of Total Revenues.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Janux Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | JANX |
Website: | januxrx.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 57.34 |
Quick Ratio: | 57.02 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
JANX Technical Analysis vs Fundamental Analysis
Sell
34
Janux Therapeutics (JANX)
is a Sell
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a Sell
The current Janux Therapeutics [JANX] share price is $41.26. The Score for JANX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.